An IRES-dependent translation of HYPK mRNA generates a truncated isoform of the protein that lacks the nuclear localization and functional ability.


Journal

RNA biology
ISSN: 1555-8584
Titre abrégé: RNA Biol
Pays: United States
ID NLM: 101235328

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 10 8 2019
medline: 30 4 2020
entrez: 10 8 2019
Statut: ppublish

Résumé

Different mechanisms of translation initiation process exist to start the protein synthesis from various viral and eukaryotic mRNA. The cap-independent and tertiary structure directed translation initiation of mRNAs forms the basis of internal ribosome entry site (IRES) mediated translation initiation that helps in cellular protein production in different conditions. HYPK protein sequesters different aggregation-prone proteins to help in the cellular proteostasis. HYPK mRNA is differentially translated from an internal start/initiation codon to generate an amino terminal-truncated isoform (HSPC136) of HYPK protein. In this study, we report that an IRES-dependent translation initiation of HYPK mRNA results in the formation of the HSPC136/HYPK-ΔN isoform of HYPK protein. The IRES-driven translation product, HYPK-ΔN, lacks the N-terminal tri-arginine motif that acts as the nuclear localization signal (NLS) in the full-length HYPK protein. While the full-length HYPK protein translocates to the nucleus and prevents the aggregation of the mutant p53 (p53-R248Q) protein, the HYPK-ΔN lacks this activity. The NLS of HYPK is not evolutionarily conserved and its exclusive presence in the HYPK of higher eukaryotic animals imparts additional advantage to the HYPK protein in tackling the cytosolic as well as nuclear protein aggregates. The presence of the NLS in full-length HYPK also allows this protein to modulate the cell cycle. These results provide a mechanistic detail of HYPK mRNA's translation initiation control by an IRES that dictates the formation of HYPC136/HYPK-ΔN which lacks the nuclear localization and functional ability.

Identifiants

pubmed: 31397627
doi: 10.1080/15476286.2019.1650612
pmc: PMC6779408
doi:

Substances chimiques

Carrier Proteins 0
HYPK protein, human 0
Internal Ribosome Entry Sites 0
Nuclear Localization Signals 0
Protein Isoforms 0
RNA, Messenger 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1604-1621

Références

Comp Funct Genomics. 2012;2012:391546
pubmed: 22536116
Biochim Biophys Acta. 2011 Sep;1813(9):1562-77
pubmed: 20977914
Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2846-2861
pubmed: 30251673
Trends Microbiol. 2017 Jul;25(7):546-561
pubmed: 28242053
PLoS One. 2012;7(7):e40788
pubmed: 22911708
J Cell Biol. 2000 Jul 10;150(1):275-81
pubmed: 10893274
Curr Genomics. 2009 Dec;10(8):550-7
pubmed: 20514217
Virus Res. 2009 Feb;139(2):166-71
pubmed: 18638512
J Biochem. 2016 Aug;160(2):69-75
pubmed: 27289017
PLoS One. 2012;7(12):e51415
pubmed: 23272104
J Biol Chem. 2012 Aug 10;287(33):28152-62
pubmed: 22715097
J Mol Biol. 2018 Mar 30;430(7):963-986
pubmed: 29458128
Hum Mol Genet. 2008 Jan 15;17(2):240-55
pubmed: 17947297
Cell Death Differ. 2005 Jun;12(6):547-53
pubmed: 15818406
Mol Cells. 2010 Oct;30(4):285-93
pubmed: 21052925
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
pubmed: 12824337
J Cell Sci. 2003 Oct 15;116(Pt 20):4077-85
pubmed: 12972501
PLoS One. 2014 Jan 21;9(1):e85552
pubmed: 24465598
Mol Cell Pharmacol. 2009;1(3):148-156
pubmed: 20300488
Nat Rev Microbiol. 2019 Jan;17(2):110-123
pubmed: 30514982
Mol Cell Biol. 2000 Dec;20(23):8635-42
pubmed: 11073965
Genes Dev. 2001 Jul 1;15(13):1593-612
pubmed: 11445534
Nat Commun. 2017 Jun 06;8:15726
pubmed: 28585574
J Biol Chem. 2005 Jun 24;280(25):23425-8
pubmed: 15749702
PLoS Genet. 2009 Mar;5(3):e1000414
pubmed: 19293945
Genes Dev. 1999 May 15;13(10):1211-33
pubmed: 10346810
Proteins. 2015 Dec;83(12):2240-50
pubmed: 26442703
Circ Res. 2007 Feb 16;100(3):305-8
pubmed: 17255526
Protein J. 2016 Aug;35(4):269-82
pubmed: 27325406
Genes Dev. 1998 Jan 1;12(1):67-83
pubmed: 9420332
RNA. 2005 Mar;11(3):332-43
pubmed: 15701733
FEBS Lett. 2018 Aug;592(16):2680-2692
pubmed: 30069866
Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10064-9
pubmed: 16002468
Biosci Rep. 2013 Jul 25;33(4):null
pubmed: 24003888
RNA. 2008 Sep;14(9):1852-64
pubmed: 18676616
Methods Mol Biol. 2014;1079:105-16
pubmed: 24170397
J Virol. 2010 Sep;84(18):9472-86
pubmed: 20592073
Virus Res. 2009 Feb;139(2):183-92
pubmed: 18675861
Biochemistry. 2018 Apr 3;57(13):2009-2023
pubmed: 29381348
Aging Cell. 2015 Feb;14(1):35-48
pubmed: 25510159
Wiley Interdiscip Rev RNA. 2014 May-Jun;5(3):301-15
pubmed: 24375939
Biochim Biophys Acta. 2014 Mar;1840(3):1181-7
pubmed: 24361604
ACS Chem Biol. 2019 May 17;14(5):901-915
pubmed: 30986346
Mol Cell Biol. 2010 Apr;30(8):1898-909
pubmed: 20154145

Auteurs

Debasish Kumar Ghosh (DK)

Computational and Functional Genomics Group, Centre for DNA Fingerprinting and Diagnostics , Hyderabad , Telangana , India.
Graduate studies, Manipal Academy of Higher Education , Manipal , Karnataka , India.

Akash Ranjan (A)

Computational and Functional Genomics Group, Centre for DNA Fingerprinting and Diagnostics , Hyderabad , Telangana , India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH